Corvus Pharmaceuticals Inc (CRVS)
EBITDA
-$51.52M
TTM · Period ending: · USD
CRVS EBITDA
Latest reported-$51.52Mperiod ending
Latest reported-$51.52Mperiod ending
CRVS EBITDA ($14.64K → -$51.52M)
Annual EBITDA
High-resolution chart · PNG
CRVS ebitda history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA (USD) |
|---|---|
| -15,178,000 | |
| -62,208,000 | |
| -26,878,000 | |
| -40,940,000 | |
| -42,766,000 | |
| -5,363,000 | |
| -48,111,000 | |
| -46,092,000 | |
| -54,821,000 | |
| -35,781,000 | |
| -31,187,000 | |
| 14,636 |